𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gas chromatographic/electron impact mass spectrometric selective confirmatory analysis of clenbuterol in human and bovine urine

✍ Scribed by Aldo Polettini; Angelo Groppi; M. Cristina Ricossa; Maria Montagna


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
383 KB
Volume
22
Category
Article
ISSN
1076-5174

No coin nor oath required. For personal study only.

✦ Synopsis


A method for the confirmatory analysis of clenbuterol in human and bovine urine was developed. After a double washing of the acidified sample with fert-butyl methyl ether (only for bovine urine), and a solid-phase extraction with Bond-Elut Certify@ columns, derivatization was performed with trimethylboroxine. The extract was then analysed by gas chromatography/electron impact mass spectrometry. The advantages of the metbylboronate derivative with respect to other derivatives are discussed in terms of chromatographic properties and, above all, of specificity of the electron impact mass spectrum. The method was successfully used for the confirmatory analyses of clenbuterol during the XXV Olympic Games of Barcelona.


πŸ“œ SIMILAR VOLUMES


Rapid Solid-phase Extraction/Derivatizat
✍ Soledad CΓ‘rdenas; Mercedes Gallego; Miguel ValcΓ‘rcel πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 216 KB πŸ‘ 2 views

A novel automatic system has been developed for the rapid solid-extraction and derivatization of different drugs and their metabolites from urine, prior to further analysis. Manual injection of underivatized/derivatized drugs in a GC/MS system, in which the quadrupole mass filter was operated conven

Validation of a gas chromatographic/mass
✍ Josiane Schoun; Bertrand DulΓ©ry; Klaus D. Haegele πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 461 KB πŸ‘ 2 views

Fhoromethylene-rn-tyrosine (FMMT, MDL 72394) represents a prodrug approach to site-selective, irreversible inhibition of monoamine oxidase. A sensitive and specific method for the quantification of FMMT and its active metabolite (MDL 72392) in human plasma and urine has been developed for future pha